Northern Swan invests millions in pharma startup Cansativa
New Milestone for Cansativa Towards “EU GxP Innovation Hub”
01-Mar-2019 -
Northern Swan, a New-York based investment firm, has invested several million euros in Cansativa GmbH, in order to further accelerate the growth of the company and its integration into the wider European market. Cansativa will use this investment to expand its current facilities to become a “EU ...
investments
medical cannabis